The Cigna Group (NYSE:CI) Shares Sold by Jump Financial LLC

Jump Financial LLC trimmed its holdings in shares of The Cigna Group (NYSE:CI - Free Report) by 62.4% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 5,333 shares of the health services provider's stock after selling 8,864 shares during the quarter. Jump Financial LLC's holdings in The Cigna Group were worth $1,473,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently added to or reduced their stakes in the company. TCTC Holdings LLC purchased a new position in The Cigna Group in the 4th quarter worth $25,000. Collier Financial purchased a new position in The Cigna Group during the 4th quarter worth approximately $32,000. ORG Wealth Partners LLC acquired a new stake in shares of The Cigna Group in the fourth quarter worth $34,000. Compagnie Lombard Odier SCmA purchased a new position in shares of The Cigna Group during the fourth quarter worth $37,000. Finally, Heck Capital Advisors LLC acquired a new position in The Cigna Group during the fourth quarter valued at $53,000. 86.99% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, insider Nicole S. Jones sold 4,904 shares of the firm's stock in a transaction on Monday, March 3rd. The stock was sold at an average price of $308.12, for a total transaction of $1,511,020.48. Following the completion of the transaction, the insider now directly owns 29,421 shares in the company, valued at $9,065,198.52. This trade represents a 14.29 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO David Cordani sold 26,527 shares of The Cigna Group stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $308.12, for a total value of $8,173,499.24. Following the completion of the sale, the chief executive officer now directly owns 127,767 shares of the company's stock, valued at $39,367,568.04. The trade was a 17.19 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 43,751 shares of company stock valued at $13,603,991 over the last 90 days. 0.70% of the stock is owned by company insiders.

The Cigna Group Trading Down 0.1 %

Shares of CI traded down $0.40 during mid-day trading on Wednesday, reaching $336.67. The stock had a trading volume of 1,782,705 shares, compared to its average volume of 1,695,447. The Cigna Group has a 52-week low of $262.03 and a 52-week high of $370.83. The firm has a market cap of $92.14 billion, a price-to-earnings ratio of 27.51, a P/E/G ratio of 0.98 and a beta of 0.51. The business's fifty day moving average is $317.24 and its 200 day moving average is $310.60. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72.

The Cigna Group (NYSE:CI - Get Free Report) last released its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 EPS for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same quarter in the previous year, the business posted $6.79 EPS. On average, sell-side analysts predict that The Cigna Group will post 29.77 EPS for the current fiscal year.

The Cigna Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, June 18th. Shareholders of record on Tuesday, June 3rd will be given a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a yield of 1.79%. The Cigna Group's payout ratio is currently 49.35%.

Analysts Set New Price Targets

Several research firms recently commented on CI. Stephens dropped their target price on The Cigna Group from $410.00 to $380.00 and set an "overweight" rating on the stock in a report on Friday, January 31st. Barclays dropped their price target on shares of The Cigna Group from $420.00 to $339.00 and set an "overweight" rating on the stock in a research note on Friday, January 31st. UBS Group reduced their price objective on shares of The Cigna Group from $410.00 to $390.00 and set a "buy" rating for the company in a research report on Monday, February 3rd. Raymond James reaffirmed a "strong-buy" rating and set a $360.00 price objective (down from $415.00) on shares of The Cigna Group in a report on Friday, January 31st. Finally, Robert W. Baird reduced their price target on shares of The Cigna Group from $388.00 to $362.00 and set an "outperform" rating for the company in a research report on Tuesday, April 15th. Two investment analysts have rated the stock with a hold rating, fifteen have assigned a buy rating and three have assigned a strong buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Buy" and a consensus target price of $373.56.

About The Cigna Group

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.